[Posted on December 10, 2007 - 5:29 PM]
E-mail
del.icio.us
Technorati
Digg
Arch Venture Partners put the finishing touches on its seventh fund, a $400 million vehicle that gives the seed and early-stage investment firm about $1.5 billion under management. ARCH Venture Fund VII LP will continue the firm's focus on newly-minted companies in the biotechnology, advanced materials and specialty semiconductor sectors.
Chicago-based Arch likes to back startups that are commercializing technology coming out of universities, national laboratories, and corporate research laboratories. Its roots go back to 1986, when it spun off from an innovative technology commercialization initiative originated by The University of Chicago.
Closing with $400 million may seem like quite a bit for a fund that will be getting in early with small investments in most of its portfolio companies, but Arch tends to continue backing its companies even into later rounds: look at its participation in a $52 million Series B for Xtera Communications, Inc. in August and a $63 million Series E for Omeros in February. -- George White
See pre Dec. 10 press releas from Arch Venture Partners
See Aug. 9 story from TheDeal.com
See Feb. 12 story from TheDeal.com
